Treatment of dyslipidaemias

EBM Guidelines
Oct 1, 2021 • Latest change Feb 12, 2024
Timo Strandberg and Hannu Vanhanen

Table of contents

Extract

  • The aim of treatment is to:
  • Lifestyle modification is of primary importance in all patients.
  • Secondary hypercholesterolaemia (associated with hypothyroidism, for instance) must be excluded before starting medication.
  • The general goal of treatment is to lower plasma LDL cholesterol levels to:
    • below 3.0 mmol/l in low risk patients
    • below 2.6 mmol/l in moderate risk patients
    • below 1.8 mmol/l in high risk patients
    • below 1.4 mmol/l, as far as possible, in very high risk patients.
  • In hypertriglyceridaemia, triglyceride levels must be below (5–)10 mmol/l to reduce the risk of pancreatitis.

Read full article of Treatment of dyslipidaemias

Search terms

Aged, Arteriosclerosis, Atherosclerosis, Blood lipids, Cardiology, Cholesterol, Cholesterol, HDL, Cholesterol, LDL, Coronary Disease, Diabetes Mellitus, Dyslipidaemia, Dyslipidemia, E78*, Endocrinology, Hypercholesterolemia, Hyperlipidemia, Hyperlipoproteinemia Type IV, Internal medicine, Intracranial Arteriosclerosis, Lipids, Statin, Statins, Triglycerides, hypercholesterolemia, secondary